Wegovy Cost 2026: Monthly Price Without Insurance
Complete breakdown of Wegovy costs in 2026 without insurance. Monthly pricing by dose, annual totals, savings card options, and how compounded semaglutide compares at $99/month.
Written by Trimi Medical Team. Medically reviewed by Dr. Amanda Foster, MD. Pricing information is updated regularly based on current market data, pharmacy surveys, and manufacturer pricing announcements.
Quick links: Semaglutide treatment, tirzepatide treatment, and best GLP-1 provider guide.
More on GLP-1 Provider Comparisons
Wegovy vs Compounded Semaglutide
Complete comparison of Wegovy and compounded semaglutide.
Wegovy Alternatives 2026
The cheapest alternatives to brand-name Wegovy.
Wegovy Savings Card vs Compounded
Which saves more: the Wegovy savings card or compounded semaglutide?
How to Get Semaglutide Cheap
Step-by-step guide to affordable semaglutide access.
Wegovy Pricing in 2026: The Full Picture
Wegovy, manufactured by Novo Nordisk, remains one of the most effective FDA-approved weight loss medications available in 2026. It also remains one of the most expensive. Understanding the complete cost picture — beyond just the sticker price — is essential for patients evaluating whether Wegovy fits their budget or whether more affordable alternatives make more financial sense.
The retail price of Wegovy without insurance hovers around $1,300 to $1,500 per month in 2026. This price applies across all dose levels of the medication — meaning you pay the same whether you are on the 0.25mg starter dose or the 2.4mg maintenance dose. This flat pricing structure means that patients in the early titration phase are paying the same amount for a fraction of the active ingredient they will eventually use at maintenance doses.
Beyond the medication cost itself, patients should account for several additional expenses that may apply depending on their healthcare pathway: provider consultation fees if not using a telehealth platform with included consultations, pharmacy dispensing fees, potential prior authorization processing costs through insurance, and follow-up visit charges. When all costs are included, the true total cost of obtaining and maintaining Wegovy treatment can exceed the retail medication price alone.
Monthly Cost by Dose Level
Wegovy follows a standard dose titration schedule, starting low and increasing gradually over approximately 16 to 20 weeks to reach the maintenance dose. Unlike many medications where the price scales with the dose, Wegovy's pricing is essentially flat — the cost per pen is the same regardless of the dose it contains.
| Dose Level | Treatment Phase | Wegovy Retail Price | Compounded Alternative |
|---|---|---|---|
| 0.25mg weekly | Weeks 1-4 | ~$1,350/mo | ~$99/mo |
| 0.5mg weekly | Weeks 5-8 | ~$1,350/mo | ~$99/mo |
| 1mg weekly | Weeks 9-12 | ~$1,350/mo | ~$149/mo |
| 1.7mg weekly | Weeks 13-16 | ~$1,350/mo | ~$149/mo |
| 2.4mg weekly | Maintenance | ~$1,350/mo | ~$199/mo |
As the table shows, the savings from compounded semaglutide are significant at every dose level. During the first two months of treatment at the lowest doses, patients using Wegovy pay over $1,300 per month for a dose that contains a small fraction of the active ingredient they will need at maintenance. Compounded semaglutide pricing through platforms like Trimi more accurately reflects the actual medication content, with lower doses priced lower.
Annual Cost Projections
Understanding the annual cost is critical because GLP-1 weight loss treatment is typically a long-term commitment. Most patients remain on treatment for 12 months or longer, and some continue indefinitely to maintain their weight loss results. The cumulative financial impact over a year or more is substantial.
At retail pricing, a full year of Wegovy costs approximately $16,200 — roughly the price of a used car, a year of in-state college tuition, or several months of mortgage payments. Over two years of treatment, that total approaches $32,400. These numbers are not sustainable for the vast majority of patients without substantial insurance support, which is why the Wegovy alternatives market has grown so rapidly.
By contrast, a year of compounded semaglutide through Trimi costs approximately $1,788 to $2,388 depending on your maintenance dose — saving patients $13,000 to $14,000 per year compared to brand-name Wegovy. Over a two-year treatment course, those savings approach $28,000. This is not a marginal difference — it is transformative for patients' ability to access and sustain treatment long enough to achieve meaningful weight loss.
Insurance Coverage Reality
The assumption that insurance will make Wegovy affordable is often incorrect. The reality of insurance coverage for GLP-1 weight loss medications in 2026 is complicated and frequently disappointing for patients who expect their plan to shoulder most of the cost.
Many employer-sponsored plans explicitly exclude anti-obesity medications from their formulary
Plans that cover Wegovy often require prior authorization, which can take weeks and may be denied
Step therapy requirements may mandate trying cheaper medications first before Wegovy is approved
High-deductible health plans mean patients pay full retail until their deductible is met
Even with coverage, specialty tier copays can be $200 to $500 per month or more
Coverage can be revoked if the insurer determines the patient does not meet ongoing criteria
Given these realities, many patients who initially pursue Wegovy through insurance end up switching to compounded semaglutide after experiencing coverage denials, extended wait times for authorization, or discovering that their out-of-pocket cost through insurance is not substantially less than the straightforward price of compounded semaglutide through a provider like Trimi.
Savings Programs and Coupons
Novo Nordisk and various third-party organizations offer savings programs for Wegovy, but these programs have important limitations that patients should understand before relying on them as their primary cost-reduction strategy.
The Novo Nordisk savings card, often promoted as a way to reduce Wegovy costs, typically requires that the patient have commercial insurance coverage as a prerequisite. Patients without insurance, those on Medicare or Medicaid, and those whose insurance explicitly excludes Wegovy generally cannot use the savings card. Even eligible patients face maximum benefit caps and program expiration dates that limit long-term savings. For a deeper analysis, see our Wegovy savings card comparison.
Patient assistance programs for uninsured or underinsured patients do exist, but they typically have income requirements, application processes, and limited slots. These programs can be valuable for eligible patients but are not a reliable pathway for the majority of people seeking weight loss treatment.
The Compounded Semaglutide Alternative
For patients who cannot afford Wegovy at retail pricing and do not have insurance coverage that makes it affordable, compounded semaglutide represents the most practical path to accessing the same active medication. The cost comparison is straightforward and dramatic:
Same active ingredient (semaglutide) at 80-90% lower cost
No insurance required — predictable monthly pricing
No prior authorization delays — medication ships within days of provider approval
Flexible month-to-month treatment with no long-term contracts
Provider consultations, medical oversight, and shipping included in the monthly price
Dosing flexibility allows custom titration not available with fixed pen doses
Trimi's compounded semaglutide pricing starts at $149 per month — a fraction of what Wegovy costs at retail. For patients who need long-term treatment to achieve and maintain significant weight loss, this price difference is the difference between being able to sustain treatment and having to discontinue due to cost.
Bottom Line
Wegovy's effectiveness is not in question — it is one of the most effective weight loss medications ever developed. The question is whether its retail price of $1,300 to $1,500 per month is sustainable for long-term treatment, and for most patients, the honest answer is no. Unless you have strong insurance coverage with low copays and no prior authorization hassles, brand-name Wegovy represents an extraordinary financial burden.
Compounded semaglutide offers the same active ingredient, the same mechanism of action, and comparable clinical results at a price point that makes long-term treatment financially viable. Through Trimi, patients access semaglutide starting at $149 per month with transparent pricing, quality pharmacy partnerships, and specialized weight management support. The savings of $13,000 or more per year versus Wegovy make compounded semaglutide the practical choice for sustainable weight loss treatment.
Frequently Asked Questions
How much does Wegovy cost per month without insurance in 2026?
Wegovy's retail price without insurance is approximately $1,300 to $1,500 per month in 2026, depending on your pharmacy and location. This price is consistent across all dose levels — the 0.25mg starter dose costs the same as the 2.4mg maintenance dose. Over a year, patients paying out of pocket can expect to spend $15,600 to $18,000 for Wegovy. By comparison, compounded semaglutide through providers like Trimi starts at $149 per month for the same active ingredient.
Does the Wegovy savings card really help?
Novo Nordisk offers a Wegovy savings card that can reduce costs for eligible patients, but it has significant limitations. The savings card typically requires commercial insurance coverage as a prerequisite — meaning patients without insurance cannot use it. Even with the card, copays may still be significant. The savings card also has a maximum benefit amount and expiration date. For patients without insurance or with high-deductible plans, the savings card often provides minimal relief compared to the alternative of using compounded semaglutide.
Is Wegovy covered by Medicare or Medicaid?
Coverage varies. Traditional Medicare Part D plans have historically not covered weight loss medications, though the landscape has been evolving. Some Medicare Advantage plans and state Medicaid programs have begun to cover GLP-1 medications for weight management, but coverage is inconsistent and often requires prior authorization. Patients on government insurance programs should verify their specific plan's coverage. Many find that compounded semaglutide at $99 to $199 per month is more affordable than navigating the uncertainty of government insurance coverage.
Why did Wegovy's price increase in 2026?
Pharmaceutical pricing in the United States is set by manufacturers and can increase annually. Novo Nordisk has adjusted Wegovy pricing based on market dynamics, demand, and their overall pricing strategy. While specific price increase percentages vary by year, the trend for brand-name GLP-1 medications has been upward. This ongoing price escalation makes the cost gap between brand-name and compounded semaglutide wider over time, strengthening the value proposition of compounded alternatives.
How does Wegovy cost compare to other brand-name GLP-1 medications?
Wegovy is among the most expensive GLP-1 medications at retail pricing. Ozempic costs approximately $900 to $1,100 per month without insurance, Mounjaro costs approximately $1,000 to $1,200 per month, and Zepbound costs approximately $1,060 per month. Wegovy's higher price reflects its specific FDA approval for chronic weight management and the premium Novo Nordisk commands for the weight-loss-specific formulation. All of these brand-name options cost 5 to 15 times more than compounded alternatives.
Can I afford Wegovy on a typical salary?
At $1,300 to $1,500 per month, Wegovy represents a significant financial commitment. For context, that is roughly equivalent to a car payment, and over a year it exceeds $15,000. For the median US household income of approximately $75,000, Wegovy would consume about 20 percent of pre-tax income. This is why most patients who lack comprehensive insurance coverage opt for compounded semaglutide, which delivers the same active ingredient at a fraction of the cost.
What is the cheapest way to get semaglutide in 2026?
The most affordable way to access semaglutide in 2026 is through compounded semaglutide from a telehealth provider. Platforms like Trimi offer compounded semaglutide starting at $149 per month, which includes the medication, provider consultations, medical oversight, and shipping. This represents savings of up to 90 percent compared to brand-name Wegovy. The active ingredient is the same — the difference is in the manufacturing source and cost structure, not the clinical effectiveness.
Sources & References
- Novo Nordisk official pricing and savings card information.
- STEP 1 trial: semaglutide 2.4mg for weight management (NEJM, 2021).
- Wegovy prescribing information from the FDA.
- Centers for Medicare and Medicaid Services — prescription drug coverage information.
- FDA guidance on drug compounding.
- NIDDK overview of prescription weight loss medications.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Pricing information is based on publicly available data and may vary by pharmacy, location, and insurance status. Always verify current pricing directly with providers. Trimi offers compounded semaglutide as an alternative — readers should be aware of our perspective.